Evidence map›Paper›PMID 29246829›Full record

ArticleHeart rhythm2018

Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions.

Luther M Swift, Huda Asfour, Narine Muselimyan, Cinnamon Larson, Kenneth Armstrong, Narine A Sarvazyan

Open access · hybridAbstract read
In one paragraph

Article in Heart rhythm, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Image-Based Monitoring of Thermal Ablation.Bioengineering (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Luther M SwiftThe George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
Huda AsfourThe George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
Narine MuselimyanThe George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
Cinnamon LarsonNocturnal Product Development, Durham, North Carolina.
Kenneth ArmstrongNocturnal Product Development, Durham, North Carolina.
Narine A SarvazyanThe George Washington University School of Medicine and Health Sciences, Washington, District of Columbia. Electronic address: phynas@gwu.edu.
George Washington University · USNocturnal Product Development (United States) · US

Funding

New generation of catheters for treatment of atrial fibrillationR42HL120511 · NHLBI · NOCTURNAL PRODUCT DEVELOPMENT, LLC · PI SARVAZYAN, NARINE · 2016 to 2017
$2.3M
New generation of catheters for treatment of atrial fibrillationR41HL120511 · NHLBI · NOCTURNAL PRODUCT DEVELOPMENT, LLC · PI SARVAZYAN, NARINE · 2014 to 2014
$200k
NHLBI NIH HHS R41 HL120511NHLBI NIH HHS R42 HL120511
6 · The paper itself

Abstract

backgroundTreatment of cardiac arrhythmias often involves ablating viable muscle tissue within or near islands of scarred myocardium. Yet, today there are limited means by which the boundaries of such scars can be visualized during surgery and distinguished from the sites of acute injury caused by radiofrequency (RF) ablation.

objectiveWe sought to explore a hyperspectral imaging (HSI) methodology to delineate and distinguish scar tissue from tissue injury caused by RF ablation.

methodsRF ablation of the ventricular surface of live rats that underwent thoracotomy was followed by a 2-month animal recovery period. During a second surgery, new RF lesions were placed next to the scarred tissue from the previous ablation procedure. The myocardial infarction model was used as an alternative way to create scar tissue.

resultsExcitation-emission matrices acquired from the sites of RF lesions, scar region, and the surrounding unablated tissue revealed multiple spectral changes. These findings justified HSI of the heart surface using illumination with 365 nm UV light while acquiring spectral images within the visible range. Autofluorescence-based HSI enabled to distinguish sites of RF lesions from scar or unablated myocardium in open-chest rats. A pilot version of a percutaneous HSI catheter was used to demonstrate the feasibility of RF lesion visualization in atrial tissue of live pigs.

conclusionHSI based on changes in tissue autofluorescence is a highly effective tool for revealing-in vivo and with high spatial resolution-surface boundaries of myocardial scar and discriminating it from areas of acute necrosis caused by RF ablation.

Indexed as

AnimalsCatheter AblationCicatrixDisease Models, AnimalFemaleHeart AtriaHeart Conduction SystemHeart VentriclesMaleMyocardiumRatsRats, Sprague-DawleySpectrometry, FluorescenceTachycardia, VentricularAblationHyperspectral imagingMyocardiumScar

Identifiers

PMID29246829
PMCPMC5879007
OpenAlexW2775102681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.